Nektar Therapeutics Analysis
| Analyst Ratings |
|
Average Target Price
|
4.41
|
|
Average Rating
|
2.73
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
8
|
|
# Sells
|
3
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.45
|
-0.31
|
0.14
|
31.11%
|
|
2022-06-30
|
-0.94
|
-0.85
|
0.09
|
9.57%
|
|
2022-03-31
|
-0.68
|
-0.49
|
0.19
|
27.94%
|
|
2021-12-31
|
-0.81
|
-0.79
|
0.02
|
2.47%
|
|
2021-09-30
|
-0.80
|
-0.70
|
0.10
|
12.50%
|
|
2021-06-30
|
-0.73
|
-0.69
|
0.04
|
5.48%
|
|
2021-03-31
|
-0.72
|
-0.68
|
0.04
|
5.56%
|
|
2020-12-31
|
-0.68
|
-0.65
|
0.03
|
4.41%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.65
|
|
2021-12-31
|
-2.86
|
|
2020-12-31
|
-2.49
|
|
2019-12-31
|
-2.51
|
|
2018-12-31
|
3.60
|
|
2017-12-31
|
-0.65
|
|
2016-12-31
|
-1.10
|
|
2015-12-31
|
-0.61
|
|
2014-12-31
|
-0.45
|
|
2013-12-31
|
-1.40
|
|
2012-12-31
|
-1.48
|
|
2011-12-31
|
-1.19
|
|
2010-12-31
|
-0.28
|
|
2009-12-31
|
-1.10
|
|
2008-12-31
|
-1.65
|
|
2007-12-31
|
-0.89
|
|
2006-12-31
|
-1.23
|
|
2005-12-31
|
-1.31
|
|
2004-12-31
|
-1.03
|
|
2003-12-31
|
-1.28
|
|
2002-12-31
|
-1.88
|
|
2001-12-31
|
-1.34
|
|
2000-12-31
|
-1.16
|
|
1999-12-31
|
-0.82
|
|
1998-12-31
|
-0.57
|
|
1997-12-31
|
-0.35
|
|
1996-12-31
|
-0.44
|
|
1995-12-31
|
-0.19
|